Skip to main content
. 2020 Nov 12;7:554669. doi: 10.3389/fmed.2020.554669

Table 1.

Population characteristics of participants from early and late KOA studies.

Earlier stage KOA study (n = 139) Later stage KOA study with MRI data (n = 20)
Age, years 55.5 ± 7.8 56.1 ± 6.5
Female (%) 82.5 65.0
BMI, kg/m 26.0 ± 5.9 28.1 ± 4.8
Ethnicity, n, (%)
Chinese 116 (81.1) 15 (75.0)
Malay 15 (10.5) 2 (10.0)
Indian 10 (7.0) 3 (15.0)
Others 2 (1.4) 0 (0)
Comorbidities, n, (%)
Hypertension 43 (30.3) 7 (35.0)
Hyperlipidemia 55 (38.7) 7 (35.0)
Diabetes mellitus 12 (8.5) 1 (5.0)
Coronary artery disease 4 (2.8) 0 (0)
Duration of KOA, years 2.5 (4.9) 7.4 (7.1)
Fulfilled ACR Clinical and Radiographical Criteria for KOA (%) 43 100
KL grade of index knee, n, (%)
0 40 (28.8) 1 (5.0)
1 44 (31.7) 5 (25.0)
2 35 (25.2) 6 (30.0)
3 18 (12.9) 5 (25.0)
4 2 (1.4) 3 (15.0)
WOMAC pain (0–100) 31.1 ± 18.4 42.1 ± 21.1
WOMAC function (0–100) 32.0 ± 19.9 44.9 ± 20.9
Biomarkers¥
(s) LBP (ng/ml) 9079.0 (6745.0, 11794.0) 9466.5 (8072.3, 10514.3)
(sf) LBP (ng/ml)£ 1796.9 (1448.5, 2416.4) 2012.9 (1579.6, 2315.6)
(s) TLR4 (pg/ml) 1049.0 (661.0, 1294.0) 699.5 (628.5, 1047.0)
(sf) TLR4 (pg/ml)£ 875.2 (12.5, 1150.5) 3845.4 (3088.5, 4092.9)
(s) CD14 (ng/ml) 1254.8 (1145.0, 1374.7) 1327.5 (1223.8, 1555.5)
(sf) CD14 (ng/ml)£ 255.3 (167.8, 400.8) 849.7 (681.5, 972.6)
(s) IL6 (pg/ml) 0.48 (0.48, 2.09) 3.35 (1.95, 5.65)
(sf) IL6 (pg/ml)£ 87.45 (24.93, 248.06) 25.62 (12.43, 63.76)
(s) IL8 (pg/ml) 0.87 (0.32, 2.21) 4.95 (3.30, 9.15)
(sf) IL8 (pg/ml)£ 5.09 (3.67, 9.22) 29.35 (24.02, 39.73)
(s) TNFα (pg/ml) 3.07 (1.10, 4.78) 4.75 (2.72, 5.66)
(sf) TNFα (pg/ml)£ 1.62 (1.30, 1.90) 0.99 (0.74, 1.23)

Knee osteoarthritis (KOA) was classified according to the American College of Rheumatology Clinical and Radiographic Criteria for KOA.

Mean ± SD.

¥

Median (interquartile range).

£

Limit to participants with direct aspiration of synovial fluid.

BMI, body mass index; KL grade, Kellgren and Lawrence grading; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index; (s), serum; (sf), synovial fluid; IL, interleukin; CD, cluster of differentiation; LBP, lipopolysaccharide binding protein; TNFα, tumor necrosis factor alpha; TLR4, Toll-like receptor 4.